JPRN-UMIN000007231招募中4 期
Examination of the nucleoside analog-PEG-IFN alpha 2a sequential therapy for Drug Free - Examination of the nucleoside analog-PEG-IFN alpha 2a sequential therapy for Drug Free
Division of Gastroenterology, Department of Internal Medicine,Kobe University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2012年4月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The patient who has the resistant to nucleic acid analog, such as Lamivudine and Entecavir 2. Severe state of liver damage (the patient who conflicts with two items or more,total bilirubin is more than 2.0 mg/dl, prothrombin time is less than 70 %, and albumin is less than 3.6 g/dl) 3. Other chronic liver disease patients such as autoimmune hepatitis or alcoholic hepatitis 4. Severe state of complication, especially, patients were not eligible if they kept the function of bone marrow, kidney, heart, or respiration 5. Pregnant woman or woman who has possibility of pregnancy or woman while suckling 6. Patient who is administering the sho-sai-ko-to 7. A patient with the previous history of interstitial pneumonia 8. Patient who has previous history of hypersensitivity for element of PEG-IFN alpha 2a or other IFNs 9. Patient who has previous history of hypersensitivity for biological products such as vaccines 10. Patient who exists in serious state of mental disease of serious depression, thought of suicide or suicide plan, etc. or with these history 11. Additionally, patient judged by doctor that participation in this study is improper
研究者
相似试验
招募中
不适用
Effect of nucleosid analog and peginterferon alfa 2a sequential therapy on patients with chronic hepatitis BChronic hepatitis BJPRN-UMIN000013811General Internal Medicine2 Kawasaki Medical School50
招募中
不适用
Examination of efficacy and safety of PEG-IFN alpha-2a for the treatment of chronic hepatitis B.chronic hepatitis BJPRN-UMIN000006649Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine100
招募中
不适用
Examination of efficacy and safety of PEG-IFN alpha-2a plus Adefovir dipivoxil for the treatment of chronic hepatitis Bchronic hepatitis BJPRN-UMIN000006659Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine50
招募中
Unknown
Assessment of efficacy and safety of PEG-IFN alpha-2a administration into patients with chronic hepatitis B on nuleoside analogueChronic hepatitis BJPRN-UMIN000015633Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Defense Medical College100
招募中
不适用
ucleotide analog and/or peginterferon alpha-2a therapy for HBeAg-negative chronic hepatitis B.HBeAg-negative chronic hepatitis BJPRN-UMIN000010594Gunma University Graduate School of Medicine35